The Tough Tech problem we are solving
Oral dysbiosis, an imbalanced oral microbiome, has been linked to various chronic illnesses. Emerging molecular screening technology offers early detection and management of conditions like gum disease, diabetes, heart disease, and neurodegenerative disorders. However, accessibility is sorely lacking, and traditional tests are slow, leading to delayed or abandoned follow-up care. Streamlining this process could transform healthcare delivery, improve outcomes, and reduce the burden on patients and the healthcare system. A rapid clinical screening platform is urgently needed to enable early diagnosis and prompt treatment initiation.
About our solution
Drūl is building a hardware device to monitor oral microbiome dysbiosis through saliva analysis. Initially targeting oral diseases, which impact 200 million Americans, Drūl’s data-driven approach detects gum disease and tooth decay risk using saliva alone. Although it is the gateway to the rest of the body, the oral cavity often goes overlooked in medicine. Drūl aims to leverage the oral-systemic link to uncover biomarkers for early detection of chronic diseases like oral cancers, diabetes, and neurological disorders.